Q
QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

24,228 signal articles · 173 in last 24h · 115,083 total before filter · latest 53m ago
173last 24h
1832last 7d
300● bullish (7d)
167● bearish (7d)
205publishers
AllMacro324Earnings877M&A104Regulatory23Product17Analyst24
Sentiment:bullishneutralbearishshow all (incl. clickbait)
Volkswagen Q2 Earnings Call Highlights
MarketBeat22d agoneutral
Volkswagen Q2 Earnings Call Highlights

Volkswagen (ETR:VOW3) reported lower first-half vehicle deliveries and weaker profit as sharply declining demand in China, U.S. tariff costs and intense competition weighed on results, while management said stronger cash generation and a growing European electric-vehicle order book showed signs of r

Bloomberg22d agoneutral
Schools Are Cutting Women’s Scholarships Even When They Don’t Have To

(Bloomberg) -- Universities and companies are scaling back or eliminating women’s scholarships as a way to avoid scrutiny from the Trump Administration, even though officials haven't explicitly barred single-sex scholarships. Most Read from BloombergRetina Chip Designed to Restore Sight to Go on Sale in EuropeHegseth Turns to UNC, Virginia Tech After Dropping Ivy LeagueApple Plans Overhaul of MacBooks, iMac in Push to Meet AI DemandTrump Rebuilds Tariffs With New Levies on 60 EconomiesAlphabet F

Novo Nordisk Seeks Injunction Against Eli Lilly in Dispute Over Weight-Loss Ads
The Wall Street Journal22d agoneutral
Novo Nordisk Seeks Injunction Against Eli Lilly in Dispute Over Weight-Loss Ads

Novo Nordisk said it asked a U.S. court to preliminarily halt rival Eli Lilly from advertising weight-loss drugs, days after accusing the Indianapolis drugmaker of using deceptive advertising to mislead consumers in a lawsuit. Friday’s preliminary injunction request, filed in the District of New Jersey, escalates legal proceedings initiated earlier this week. Novo has now asked the court to stop Eli Lilly from advertising its GLP-1 drugs while the lawsuit proceeds.

Sportswear giant continues store closures nationwide
TheStreet22d agoneutral
Sportswear giant continues store closures nationwide

The world's largest sportswear company has accelerated a wave of store closures across the U.S., shutting down roughly a dozen locations in a single month as it works to reshape its retail footprint. The move comes at a time when competition across the athletic apparel industry is intensifying. ...

Stock Futures Rise as Oil Prices Dip After AI Selloff
Barrons.com22d agobearish
Stock Futures Rise as Oil Prices Dip After AI Selloff

Stocks looked set to struggle for direction on Friday as a drop in oil prices eased fears about higher inflation, even as artificial-intelligence jitters lingered. Nasdaq 100 futures rose 0.1%. The Dow was on track to outperform the other two major indexes because it tends to be more reactive to oil prices, which were retreating having spiked above $100 a barrel the previous session.

New Home Sales: What to Watch Friday
The Wall Street Journal22d agoneutral
New Home Sales: What to Watch Friday

Today Earnings: American Express, Verizon, Charter Communications, HCA Healthcare, Volkswagen, Canadian National Railway Economic data: Commerce Department data on new home sales for June, S&P flash U.

Moody's (MCO) Earnings Beat Puts Valuation Back In Focus
Simply Wall St.22d agobullish
Moody's (MCO) Earnings Beat Puts Valuation Back In Focus

Moody's (MCO) is back in focus after reporting second quarter results that exceeded market expectations, lifting full year guidance and pairing that update with a larger share repurchase plan. See our latest analysis for Moody's. The earnings beat and guidance upgrade come after a choppy few months for Moody's, with the share price down 9.01% over the past week but still showing a 3.55% 90 day share price return and a 37.73% three year total shareholder return. This suggests that longer term...